Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

BACKGROUND: Transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (HCC) is often repeated until unTACEable progression (UTP) occurs. There is little data on the various reasons for stopping TACE and its consequences for subsequent treatment and survival. AIM: To asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Labeur, Tim A., Takkenberg, R. Bart, Klümpen, Heinz-Josef, van Delden, Otto M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344387/
https://www.ncbi.nlm.nih.gov/pubmed/30488302
http://dx.doi.org/10.1007/s00270-018-2118-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344387/
https://www.ncbi.nlm.nih.gov/pubmed/30488302
http://dx.doi.org/10.1007/s00270-018-2118-6

Ejemplares similares